Tamura, Yoshiaki
Ishikawa, Joji
Fujiwara, Yoshinori
Tanaka, Masashi
Kanazawa, Nobuo
Chiba, Yuko
Iizuka, Ai
Kaito, Sho
Tanaka, Jun
Sugie, Masamitsu
Nishimura, Takashi
Kanemaru, Akiko
Shimoji, Keigo
Hirano, Hirohiko
Furuta, Ko
Kitamura, Akihiko
Seino, Satoshi
Shinkai, Shoji
Harada, Kazumasa
Kyo, Shunei
Ito, Hideki
Araki, Atsushi
Funding for this research was provided by:
the National Center for Geriatrics and Gerontology (28-30)
Article History
Received: 22 February 2018
Accepted: 18 October 2018
First Online: 6 November 2018
Ethics approval and consent to participate
: Written informed consent was obtained from all of the participants. For some patients recognized as cognitively impaired, we obtained proxy consent from a family member or another supportive adult on their behalf. This study was approved by the ethical committee of Tokyo Metropolitan Geriatric Hospital.
: Not applicable
: Araki A has received speaker honoraria from pharmaceutical companies, Merck Sharp & Dohme, Dainippon Sumitomo Parma Co. Ltd., Kyowa Hakko Kirin Co. Ltd., Astellas Pharma Inc., AstraZeneca, Astellas Pharma Inc., Tanabe Mitsubishi Pharma Corporation, Eli Lilly Japan Co. Ltd., Ono Pharmaceutical Co. Ltd., Taisho Toyama Pharmaceutical Co. Ltd., Novo Nordisk Pharma Ltd., Takeda Pharmaceutical Co. Ltd., Boehringer Ingelheim GmbH, and Novartis Pharma Co. Ltd.zaRitzĀ® was provided free of charge by Tanita Corp.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.